Biocon Ltd, a leading biopharmaceutical company, has been given an "Accumulate" rating by Geojit Financial Services with a target price of Rs. 376.

Morningstar has reiterated a ‘Buy’ rating for AstraZeneca (NASDAQ: AZN) with a fair value estimate of $78 per share, which represents a potential upside from the current market price of $65.19.

Argus Research has reiterated a ‘Buy’ recommendation for Novo Nordisk (NVO), setting a target price of $140, which indicates a potential upside from its current trading price of $107.

KRChoksey Research has issued a BUY recommendation for Aurobindo Pharma Ltd with a target price (TP) of Rs 1,591, suggesting a 25.6% potential upside from the current market price of Rs 1,267.

Zydus Lifesciences (ZYDUSLIF) has shown resilience in the face of recent stock price corrections and rising competition in the U.S. generics market.

Prabhudas Lilladher has issued an Accumulate rating on Aurobindo Pharma Ltd. (ARBP), setting a target price of Rs 1,475.